Shares of vaccine makers plunged after President-elect Donald Trump nominated Robert F. Kennedy Jr. to run the Department of ...

Shares of prominent vaccine makers plunged Thursday after President-elect Donald Trump announced his pick of Robert F.

Wolfe Research analyst Alexandria Hammond initiated coverage of Moderna (MRNA) with an Underperform rating and $40 price target Moderna may ...

President-elect Donald Trump said he is tapping Robert F. Kennedy Jr., to run the Department of Health and Human Services, a ...

Trump announced his decision in a tweet following media reports that Kennedy would be his choice to lead the federal health ...

Shares of vaccine makers fell on reports that President-elect Donald Trump is expected to nominate Robert F. Kennedy Jr., a ...

The Washington State Employment Security Department said in the filing that 72 employees will be laid off on Jan. 17. A ...

Shares of vaccine makers fell as President-elect Donald Trump nominated Robert F. Kennedy Jr., a prominent vaccine skeptic, ...

Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

On the other hand, Moderna Inc (NASDAQ: MRNA) posted a surprise profit and higher than expected revenue following the launch ...

Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective ...